AstraZeneca PLC (AZN), Cubist Pharmaceuticals, Inc. (CBST), Astellas Pharma Inc. (YPH.BE) Said to Make Bids for Optimer Pharmaceuticals, Inc. (OPTR)
5/15/2013 8:19:07 AM
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Appoints Eric Sirota as Chief Operating Officer
5/14/2013 6:43:36 AM
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Reports First Quarter 2013 Financial Results
5/10/2013 6:28:37 AM
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results
5/2/2013 7:38:01 AM
More...
|
Optimer Pharmaceuticals, Inc. (OPTR)'s DIFICID® Tablets Approved in Australia
4/26/2013 7:09:42 AM
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Said to Draw Takeover Interest From GlaxoSmithKline (GSK), Astellas Pharma Inc. (YPH.BE)
4/2/2013 8:00:24 AM
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3/15/2013 10:14:08 AM
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Reports Fourth Quarter and Fiscal Year 2012 Financial Results
3/1/2013 7:40:39 AM
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Names Dr. Henry McKinnell as CEO
2/27/2013 7:26:35 AM
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Release: New Analysis Shows Age Has a Significant Effect on Outcomes in Patients Being Treated for Clostridium Difficile Infection (CDI)
2/14/2013 8:58:05 AM
More...
|
|